Article abstract


Nature Immunology 9, 873 - 879 (2008)
Published online: 22 June 2008 | doi:10.1038/ni.1627

Resolvin E1 regulates interleukin 23, interferon-big gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

Oliver Haworth1, Manuela Cernadas1, Rong Yang2, Charles N Serhan2 & Bruce D Levy1,2


Interleukin 23 (IL-23) is integral to the pathogenesis of chronic inflammation. The resolution of acute inflammation is an active process mediated by specific signals and mediators such as resolvin E1 (RvE1). Here we provide evidence that RvE1, in nanogram quantities, promoted the resolution of inflammatory airway responses in part by directly suppressing the production of IL-23 and IL-6 in the lung. Also contributing to the pro-resolution effects of RvE1 treatment were higher concentrations of interferon-gamma in the lungs of RvE1-treated mice. Our findings indicate a pivotal function for IL-23 and IL-6, which promote the survival and differentiation of IL-17-producing T helper cells, in maintaining inflammation and also identify an RvE1-initiated resolution program for allergic airway responses.

Top
  1. Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Boston, Massachusetts 02115, USA.
  2. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

Correspondence to: Bruce D Levy1,2 e-mail: blevy@partners.org



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

'Good' lipids for asthma

Nature Medicine News and Views (01 Sep 2002)

Breathing easier with breast milk

Nature Medicine News and Views (01 Feb 2008)

See all 5 matches for News And Views

Extra navigation

Subscribe to Nature Immunology

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT